World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
81
Citations
29475
World Ranking
3818
National Ranking
1890

Medicine

D-Index
81
Citations
29551
World Ranking
16475
National Ranking
8281

Overview

Paul E. Sax is affiliated with Brigham and Women's Hospital in the United States. Their research primarily focuses on the field of Medicine, with a strong emphasis on Infectious Diseases and related subfields such as Virology, Emergency Medicine, Epidemiology, and Neurology.

The scientist has contributed extensively to topics related to HIV/AIDS and COVID-19. Key areas of work cover:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research

Paul E. Sax's recent scholarly publications include:

  • "Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors," 2020, Annals of Internal Medicine
  • "Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults," 2022, JAMA
  • "Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults," 2020, JAMA
  • "Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019," 2020, Clinical Infectious Diseases
  • "Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial," 2021, The Lancet

Frequent co-authors collaborating with Paul E. Sax include:

  • David A. Wohl
  • Essy Mozaffari
  • Chloe Orkin
  • Joseph J. Eron
  • Eric S. Daar

Over the course of their career, Paul E. Sax has published extensively in prominent infectious disease and medical journals. The most common venues for their work include:

  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • UNC Libraries
  • JAMA
  • The Lancet HIV

Best Publications

  • Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

    Eric S. Rosenberg;James M. Billingsley;Angela M. Caliendo;Steven L. Boswell

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy

    Colleen Hadigan;James B. Meigs;Colleen Corcoran;Petra Rietschel

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio

  • Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors.

    Eric A. Meyerowitz;Aaron Richterman;Rajesh T. Gandhi;Paul E. Sax

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

    Paul E Sax;David Wohl;Michael T Yin;Frank Post

  • The Survival Benefits of AIDS Treatment in the United States

    Rochelle P. Walensky;Rochelle P. Walensky;A. David Paltiel;Elena Losina;Lauren M. Mercincavage

  • Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

    Paul E. Sax;Kristine M. Erlandson;Jordan E. Lake;Grace A. McComsey

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

    Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy

  • Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

    Grace A. McComsey;Douglas Kitch;Eric S. Daar;Camlin Tierney

  • Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

    Paul E. Sax;Edwin DeJesus;Anthony Mills;Andrew Zolopa

  • The lifetime cost of current human immunodeficiency virus care in the United States.

    Bruce R. Schackman;Kelly A. Gebo;Rochelle P. Walensky;Elena Losina

  • Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

    Susanna Naggie;Curtis Cooper;Michael Saag;Kimberly Workowski

  • Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection

    Marcus Altfeld;Eric S. Rosenberg;Raj Shankarappa;Joia S. Mukherjee

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

    Michael S. Saag;Rajesh T. Gandhi;Jennifer F. Hoy;Raphael J. Landovitz

  • Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

    Judith S. Currier;Jens D. Lundgren;Andrew Carr;Daniel Klein

  • Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial.

    Colleen Hadigan;Colleen Corcoran;Nesli Basgoz;Benjamin Davis

  • Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials

    Jean B. Nachega;Jean Jacques Parienti;Olalekan A. Uthman;Olalekan A. Uthman;Olalekan A. Uthman;Robert Gross

  • Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

    Paul E. Sax;Camlin Tierney;Ann C. Collier;Margaret A. Fischl

  • Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

    Antonella Castagna;Franco Maggiolo;Giovanni Penco;David Wright

Frequent Co-Authors

Kenneth A. Freedberg
Kenneth A. Freedberg Harvard University
Rochelle P. Walensky
Rochelle P. Walensky Harvard University
Eric S. Daar
Eric S. Daar Lundquist Institute
Elena Losina
Elena Losina Brigham and Women's Hospital
Edwin DeJesus
Edwin DeJesus Hanover University of Applied Sciences and Arts
Milton C. Weinstein
Milton C. Weinstein Harvard University
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Grace A. McComsey
Grace A. McComsey Case Western Reserve University
Graeme Moyle
Graeme Moyle Chelsea and Westminster Hospital NHS Foundation Trust
Chloe Orkin
Chloe Orkin Queen Mary University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

With a strong foundation in Biology and Biochemistry, students can explore a variety of related online degrees that open doors to rewarding careers in science and healthcare. Flexible learning options make it easier to upskill or specialize while accommodating work or family commitments.

For those interested in leadership roles within healthcare organizations, a phd in healthcare administration online offers advanced training in management and policy. Aspiring pharmacists can gain clinical and research expertise through reputable pharmd online programs designed to prepare students for licensure and practice.

If your interests lean toward fitness, sports, or health promotion, consider the best online exercise science degree to learn about human movement, physiology, and wellness. Alternatively, an online kinesiology bachelor's degree is ideal for students who want to work in rehabilitation, athletic training, or physical therapy.

Each of these online programs supports career growth and specialization, helping graduates remain competitive in the evolving fields of biology and health sciences.

Best Scientists Citing Paul E. Sax

Trending Scientists